Stem cell trial offers hope for cancer survivors with weakened hearts
NCT ID NCT02962661
Summary
This early-stage study is testing whether stem cells from donor bone marrow can help improve heart function in cancer survivors who developed heart damage from certain chemotherapy drugs. Researchers will compare two different methods of delivering the stem cells (through an IV or directly into the heart muscle) against standard heart failure care alone. The main goal is to check if the treatments are safe, while also looking for signs they might help the heart pump better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.